VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices reports that it has filed a provisional patent application titled, “Sample Delivery Systems and Methods for Low Volatility Analytes Obtained from Breath”. This provisional patent application covers new innovations and intellectual property related to the detection of low and semi-volatile substances (like delta-9 THC) using its proprietary Mass Spectrometer Breath Sampler (“MSBS”) technology. The MSBS is an innovative hardware device which allows for direct desorption of human breath samples into a mass spectrometer without the need for any pre-preparation (see Figure 1). The MSBS substantially simplifies laboratory analysis methods, reduces sample turnaround times (within a few minutes), and provides a truly novel method for drug screening using breath.